Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03098628Phase 3Completed
A Phase 3 trial of pneumococcal conjugate vaccine, Prevnar 13 in pneumococcal infection, sponsored by Murdoch Children's Research Institute. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03098628.